Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Medicare reimbursement policy for ambulatory blood pressure monitoring: A qualitative analysis of public comments to the Centers for Medicare and Medicaid Services.

Dixon DL, Salgado TM, Luther JM, Byrd JB.

J Clin Hypertens (Greenwich). 2019 Oct 23. doi: 10.1111/jch.13719. [Epub ahead of print]

2.

Current Status of Angiotensin Receptor Blocker Recalls.

Gunasekaran PM, Chertow GM, Bhalla V, Byrd JB.

Hypertension. 2019 Dec;74(6):1275-1278. doi: 10.1161/HYPERTENSIONAHA.119.13955. Epub 2019 Oct 21.

PMID:
31630573
3.

For what factors should we normalize urinary extracellular mRNA biomarkers?

Gunasekaran PM, Luther JM, Byrd JB.

Biomol Detect Quantif. 2019 Apr 23;17:100090. doi: 10.1016/j.bdq.2019.100090. eCollection 2019 Mar. Review.

4.

Privacy-Preserving Generative Deep Neural Networks Support Clinical Data Sharing.

Beaulieu-Jones BK, Wu ZS, Williams C, Lee R, Bhavnani SP, Byrd JB, Greene CS.

Circ Cardiovasc Qual Outcomes. 2019 Jul;12(7):e005122. doi: 10.1161/CIRCOUTCOMES.118.005122. Epub 2019 Jul 9.

PMID:
31284738
5.

Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017.

Clayton A, Buschmann D, Byrd JB, Carter DRF, Cheng L, Compton C, Daaboul G, Devitt A, Falcon-Perez JM, Gardiner C, Gustafson D, Harrison P, Helmbrecht C, Hendrix A, Hill A, Hoffman A, Jones JC, Kalluri R, Kang JY, Kirchner B, Lässer C, Lawson C, Lenassi M, Levin C, Llorente A, Martens-Uzunova ES, Möller A, Musante L, Ochiya T, Pink RC, Tahara H, Wauben MHM, Webber JP, Welsh JA, Witwer KW, Yin H, Nieuwland R.

J Extracell Vesicles. 2018 May 17;7(1):1473707. doi: 10.1080/20013078.2018.1473707. eCollection 2018.

6.

Clinical research using extracellular vesicles: insights from the International Society for Extracellular Vesicles 2018 Annual Meeting.

Rayyan M, Zheutlin A, Byrd JB.

J Extracell Vesicles. 2018 Oct 26;7(1):1535744. doi: 10.1080/20013078.2018.1535744. eCollection 2018.

7.

Hypertension.

Byrd JB, Brook RD.

Ann Intern Med. 2019 May 7;170(9):ITC65-ITC80. doi: 10.7326/AITC201905070.

PMID:
31060074
8.

Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls.

Byrd JB, Chertow GM, Bhalla V.

N Engl J Med. 2019 Apr 25;380(17):1589-1591. doi: 10.1056/NEJMp1901657. Epub 2019 Mar 13. No abstract available.

9.

Score one for the clinical trial data sharing experiment.

Byrd JB.

Eur J Prev Cardiol. 2019 Apr;26(6):567-568. doi: 10.1177/2047487318821770. Epub 2019 Jan 6. No abstract available.

PMID:
30861697
10.

Strengthening a societal tie and other new initiatives for 2019.

Stowasser M, Nadar SK, Byrd JB.

J Hum Hypertens. 2019 Mar;33(3):173. doi: 10.1038/s41371-019-0172-4. Epub 2019 Mar 7. No abstract available.

PMID:
30846845
11.

Personalized Medicine and the Treatment of Hypertension.

Melville S, Byrd JB.

Curr Hypertens Rep. 2019 Feb 12;21(2):13. doi: 10.1007/s11906-019-0921-3. Review.

PMID:
30747306
12.

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach JM, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, Blenkiron C, Bobis-Wozowicz S, Boilard E, Boireau W, Bongiovanni A, Borràs FE, Bosch S, Boulanger CM, Breakefield X, Breglio AM, Brennan MÁ, Brigstock DR, Brisson A, Broekman ML, Bromberg JF, Bryl-Górecka P, Buch S, Buck AH, Burger D, Busatto S, Buschmann D, Bussolati B, Buzás EI, Byrd JB, Camussi G, Carter DR, Caruso S, Chamley LW, Chang YT, Chen C, Chen S, Cheng L, Chin AR, Clayton A, Clerici SP, Cocks A, Cocucci E, Coffey RJ, Cordeiro-da-Silva A, Couch Y, Coumans FA, Coyle B, Crescitelli R, Criado MF, D'Souza-Schorey C, Das S, Datta Chaudhuri A, de Candia P, De Santana EF, De Wever O, Del Portillo HA, Demaret T, Deville S, Devitt A, Dhondt B, Di Vizio D, Dieterich LC, Dolo V, Dominguez Rubio AP, Dominici M, Dourado MR, Driedonks TA, Duarte FV, Duncan HM, Eichenberger RM, Ekström K, El Andaloussi S, Elie-Caille C, Erdbrügger U, Falcón-Pérez JM, Fatima F, Fish JE, Flores-Bellver M, Försönits A, Frelet-Barrand A, Fricke F, Fuhrmann G, Gabrielsson S, Gámez-Valero A, Gardiner C, Gärtner K, Gaudin R, Gho YS, Giebel B, Gilbert C, Gimona M, Giusti I, Goberdhan DC, Görgens A, Gorski SM, Greening DW, Gross JC, Gualerzi A, Gupta GN, Gustafson D, Handberg A, Haraszti RA, Harrison P, Hegyesi H, Hendrix A, Hill AF, Hochberg FH, Hoffmann KF, Holder B, Holthofer H, Hosseinkhani B, Hu G, Huang Y, Huber V, Hunt S, Ibrahim AG, Ikezu T, Inal JM, Isin M, Ivanova A, Jackson HK, Jacobsen S, Jay SM, Jayachandran M, Jenster G, Jiang L, Johnson SM, Jones JC, Jong A, Jovanovic-Talisman T, Jung S, Kalluri R, Kano SI, Kaur S, Kawamura Y, Keller ET, Khamari D, Khomyakova E, Khvorova A, Kierulf P, Kim KP, Kislinger T, Klingeborn M, Klinke DJ 2nd, Kornek M, Kosanović MM, Kovács ÁF, Krämer-Albers EM, Krasemann S, Krause M, Kurochkin IV, Kusuma GD, Kuypers S, Laitinen S, Langevin SM, Languino LR, Lannigan J, Lässer C, Laurent LC, Lavieu G, Lázaro-Ibáñez E, Le Lay S, Lee MS, Lee YXF, Lemos DS, Lenassi M, Leszczynska A, Li IT, Liao K, Libregts SF, Ligeti E, Lim R, Lim SK, Linē A, Linnemannstöns K, Llorente A, Lombard CA, Lorenowicz MJ, Lörincz ÁM, Lötvall J, Lovett J, Lowry MC, Loyer X, Lu Q, Lukomska B, Lunavat TR, Maas SL, Malhi H, Marcilla A, Mariani J, Mariscal J, Martens-Uzunova ES, Martin-Jaular L, Martinez MC, Martins VR, Mathieu M, Mathivanan S, Maugeri M, McGinnis LK, McVey MJ, Meckes DG Jr, Meehan KL, Mertens I, Minciacchi VR, Möller A, Møller Jørgensen M, Morales-Kastresana A, Morhayim J, Mullier F, Muraca M, Musante L, Mussack V, Muth DC, Myburgh KH, Najrana T, Nawaz M, Nazarenko I, Nejsum P, Neri C, Neri T, Nieuwland R, Nimrichter L, Nolan JP, Nolte-'t Hoen EN, Noren Hooten N, O'Driscoll L, O'Grady T, O'Loghlen A, Ochiya T, Olivier M, Ortiz A, Ortiz LA, Osteikoetxea X, Østergaard O, Ostrowski M, Park J, Pegtel DM, Peinado H, Perut F, Pfaffl MW, Phinney DG, Pieters BC, Pink RC, Pisetsky DS, Pogge von Strandmann E, Polakovicova I, Poon IK, Powell BH, Prada I, Pulliam L, Quesenberry P, Radeghieri A, Raffai RL, Raimondo S, Rak J, Ramirez MI, Raposo G, Rayyan MS, Regev-Rudzki N, Ricklefs FL, Robbins PD, Roberts DD, Rodrigues SC, Rohde E, Rome S, Rouschop KM, Rughetti A, Russell AE, Saá P, Sahoo S, Salas-Huenuleo E, Sánchez C, Saugstad JA, Saul MJ, Schiffelers RM, Schneider R, Schøyen TH, Scott A, Shahaj E, Sharma S, Shatnyeva O, Shekari F, Shelke GV, Shetty AK, Shiba K, Siljander PR, Silva AM, Skowronek A, Snyder OL 2nd, Soares RP, Sódar BW, Soekmadji C, Sotillo J, Stahl PD, Stoorvogel W, Stott SL, Strasser EF, Swift S, Tahara H, Tewari M, Timms K, Tiwari S, Tixeira R, Tkach M, Toh WS, Tomasini R, Torrecilhas AC, Tosar JP, Toxavidis V, Urbanelli L, Vader P, van Balkom BW, van der Grein SG, Van Deun J, van Herwijnen MJ, Van Keuren-Jensen K, van Niel G, van Royen ME, van Wijnen AJ, Vasconcelos MH, Vechetti IJ Jr, Veit TD, Vella LJ, Velot É, Verweij FJ, Vestad B, Viñas JL, Visnovitz T, Vukman KV, Wahlgren J, Watson DC, Wauben MH, Weaver A, Webber JP, Weber V, Wehman AM, Weiss DJ, Welsh JA, Wendt S, Wheelock AM, Wiener Z, Witte L, Wolfram J, Xagorari A, Xander P, Xu J, Yan X, Yáñez-Mó M, Yin H, Yuana Y, Zappulli V, Zarubova J, Žėkas V, Zhang JY, Zhao Z, Zheng L, Zheutlin AR, Zickler AM, Zimmermann P, Zivkovic AM, Zocco D, Zuba-Surma EK.

J Extracell Vesicles. 2018 Nov 23;7(1):1535750. doi: 10.1080/20013078.2018.1535750. eCollection 2018.

13.

Monitoring Blood Pressure Outside of the Doctor's Office.

Melville S, Byrd JB.

JAMA. 2018 Nov 6;320(17):1830. doi: 10.1001/jama.2018.11644. No abstract available.

PMID:
30398605
14.

Out-of-Office Blood Pressure Monitoring in 2018.

Melville S, Byrd JB.

JAMA. 2018 Nov 6;320(17):1805-1806. doi: 10.1001/jama.2018.14865. No abstract available.

PMID:
30398589
15.

Primary Aldosteronism.

Byrd JB, Turcu AF, Auchus RJ.

Circulation. 2018 Aug 21;138(8):823-835. doi: 10.1161/CIRCULATIONAHA.118.033597. Review.

16.

Human Urinary mRNA as a Biomarker of Cardiovascular Disease.

Bazzell BG, Rainey WE, Auchus RJ, Zocco D, Bruttini M, Hummel SL, Byrd JB.

Circ Genom Precis Med. 2018 Sep;11(9):e002213. doi: 10.1161/CIRCGEN.118.002213.

17.

Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.

Nanba AT, Wannachalee T, Shields JJ, Byrd JB, Rainey WE, Auchus RJ, Turcu AF.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):487-492. doi: 10.1210/jc.2018-01299.

18.

Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial.

Byrd JB, Newby DE, Anderson JA, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez FJ, Vestbo J, Yates J, Brook RD; SUMMIT Investigators.

Eur Heart J. 2018 Sep 1;39(33):3128-3134. doi: 10.1093/eurheartj/ehy451.

PMID:
30101300
19.

Opening Opportunities With Open Data.

Zheutlin AR, Byrd JB.

JACC Heart Fail. 2018 Jun;6(6):530-532. doi: 10.1016/j.jchf.2017.12.019. Epub 2018 Apr 11. Review. No abstract available.

20.

Use of physician-recommended non-pharmacological strategies for hypertension control among hypertensive patients.

Liu X, Byrd JB, Rodriguez CJ.

J Clin Hypertens (Greenwich). 2018 Mar;20(3):518-527. doi: 10.1111/jch.13203. Epub 2018 Feb 15.

21.

Phase II prospective randomized trial of weight loss prior to radical prostatectomy.

Henning SM, Galet C, Gollapudi K, Byrd JB, Liang P, Li Z, Grogan T, Elashoff D, Magyar CE, Said J, Cohen P, Aronson WJ.

Prostate Cancer Prostatic Dis. 2018 Jun;21(2):212-220. doi: 10.1038/s41391-017-0001-1. Epub 2017 Dec 4.

22.

Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism.

Nanba AT, Nanba K, Byrd JB, Shields JJ, Giordano TJ, Miller BS, Rainey WE, Auchus RJ, Turcu AF.

Clin Endocrinol (Oxf). 2017 Dec;87(6):665-672. doi: 10.1111/cen.13442. Epub 2017 Sep 4.

23.

Data-Sharing Models

Byrd JB, Greene CS.

N Engl J Med. 2017 Jun 8;376(23):2305. doi: 10.1056/NEJMc1705477. No abstract available.

PMID:
28594152
24.

Reach Out Churches: A Community-Based Participatory Research Pilot Trial to Assess the Feasibility of a Mobile Health Technology Intervention to Reduce Blood Pressure Among African Americans.

Skolarus LE, Cowdery J, Dome M, Bailey S, Baek J, Byrd JB, Hartley SE, Valley SC, Saberi S, Wheeler NC, McDermott M, Hughes R, Shanmugasundaram K, Morgenstern LB, Brown DL.

Health Promot Pract. 2018 Jul;19(4):495-505. doi: 10.1177/1524839917710893. Epub 2017 Jun 5.

25.

EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research.

EV-TRACK Consortium, Van Deun J, Mestdagh P, Agostinis P, Akay Ö, Anand S, Anckaert J, Martinez ZA, Baetens T, Beghein E, Bertier L, Berx G, Boere J, Boukouris S, Bremer M, Buschmann D, Byrd JB, Casert C, Cheng L, Cmoch A, Daveloose D, De Smedt E, Demirsoy S, Depoorter V, Dhondt B, Driedonks TA, Dudek A, Elsharawy A, Floris I, Foers AD, Gärtner K, Garg AD, Geeurickx E, Gettemans J, Ghazavi F, Giebel B, Kormelink TG, Hancock G, Helsmoortel H, Hill AF, Hyenne V, Kalra H, Kim D, Kowal J, Kraemer S, Leidinger P, Leonelli C, Liang Y, Lippens L, Liu S, Lo Cicero A, Martin S, Mathivanan S, Mathiyalagan P, Matusek T, Milani G, Monguió-Tortajada M, Mus LM, Muth DC, Németh A, Nolte-'t Hoen EN, O'Driscoll L, Palmulli R, Pfaffl MW, Primdal-Bengtson B, Romano E, Rousseau Q, Sahoo S, Sampaio N, Samuel M, Scicluna B, Soen B, Steels A, Swinnen JV, Takatalo M, Thaminy S, Théry C, Tulkens J, Van Audenhove I, van der Grein S, Van Goethem A, van Herwijnen MJ, Van Niel G, Van Roy N, Van Vliet AR, Vandamme N, Vanhauwaert S, Vergauwen G, Verweij F, Wallaert A, Wauben M, Witwer KW, Zonneveld MI, De Wever O, Vandesompele J, Hendrix A.

Nat Methods. 2017 Feb 28;14(3):228-232. doi: 10.1038/nmeth.4185.

PMID:
28245209
26.
27.

Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.

Straka BT, Ramirez CE, Byrd JB, Stone E, Woodard-Grice A, Nian H, Yu C, Banerji A, Brown NJ.

J Allergy Clin Immunol. 2017 Jul;140(1):242-248.e2. doi: 10.1016/j.jaci.2016.09.051. Epub 2016 Nov 29.

28.

PRIMARY ALDOSTERONISM IN THE PRIMARY CARE CLINIC: RIFE OR RARE?

Byrd JB.

Endocr Pract. 2016 Nov;22(11):1350-1352. Epub 2016 Sep 28. No abstract available.

PMID:
27682352
29.

Serum Cortisol-to-Cortisone Ratio and Blood Pressure in Severe Obesity before and after Weight Loss.

Byrd JB, Rothberg AE, Chomic R, Burant CF, Brook RD, Auchus RJ.

Cardiorenal Med. 2015 Dec;6(1):1-7. doi: 10.1159/000438462. Epub 2015 Sep 9.

30.

Personalized medicine and treatment approaches in hypertension: current perspectives.

Byrd JB.

Integr Blood Press Control. 2016 Apr 6;9:59-67. doi: 10.2147/IBPC.S74320. eCollection 2016. Review.

31.

Acute increase in blood pressure during inhalation of coarse particulate matter air pollution from an urban location.

Byrd JB, Morishita M, Bard RL, Das R, Wang L, Sun Z, Spino C, Harkema J, Dvonch JT, Rajagopalan S, Brook RD.

J Am Soc Hypertens. 2016 Feb;10(2):133-139.e4. doi: 10.1016/j.jash.2015.11.015. Epub 2015 Nov 26.

PMID:
26750378
32.

Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study.

Byrd JB, Auchus RJ, White PC.

J Investig Med. 2015 Oct;63(7):862-6. doi: 10.1097/JIM.0000000000000220.

33.

Resistance to recommending exercise in hypertension?

Byrd JB.

J Hum Hypertens. 2015 Jun;29(6):340-1. doi: 10.1038/jhh.2014.105. Epub 2014 Nov 13. No abstract available.

PMID:
25391761
34.

Clopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: insights from the Veterans Affairs CART Program.

Byrd JB, Maddox TM, O'Donnell CI, Grunwald GK, Bhatt DL, Tsai TT, Rumsfeld JS, Ho PM.

Am Heart J. 2014 Sep;168(3):340-5. doi: 10.1016/j.ahj.2014.05.012. Epub 2014 Jun 6.

PMID:
25173546
35.

Anxiety in the "age of hypertension".

Byrd JB, Brook RD.

Curr Hypertens Rep. 2014 Oct;16(10):486. doi: 10.1007/s11906-014-0486-0. Review.

PMID:
25164965
36.

Pollen count and presentation of angiotensin-converting enzyme inhibitor-associated angioedema.

Straka B, Nian H, Sloan C, Byrd JB, Woodard-Grice A, Yu C, Stone E, Steven G, Hartert T, Teo KK, Pare G, McCarty CA, Brown NJ.

J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):468-73.e1-4. doi: 10.1016/j.jaip.2013.05.003. Epub 2013 Jun 21.

37.

The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension.

Byrd JB, Bakris G, Jamerson K.

Curr Hypertens Rep. 2014 Mar;16(3):419. doi: 10.1007/s11906-014-0419-y. Review.

PMID:
24474031
38.

Arm position during ambulatory blood pressure monitoring: a review of the evidence and clinical guidelines.

Byrd JB, Brook RD.

J Clin Hypertens (Greenwich). 2014 Mar;16(3):225-30. doi: 10.1111/jch.12255. Epub 2014 Jan 28. Review.

39.

Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy.

Galet C, Gollapudi K, Stepanian S, Byrd JB, Henning SM, Grogan T, Elashoff D, Heber D, Said J, Cohen P, Aronson WJ.

Cancer Prev Res (Phila). 2014 Jan;7(1):97-104. doi: 10.1158/1940-6207.CAPR-13-0261. Epub 2013 Oct 29.

40.

Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema.

Pare G, Kubo M, Byrd JB, McCarty CA, Woodard-Grice A, Teo KK, Anand SS, Zuvich RL, Bradford Y, Ross S, Nakamura Y, Ritchie M, Brown NJ.

Pharmacogenet Genomics. 2013 Sep;23(9):470-8. doi: 10.1097/FPC.0b013e328363c137.

41.

A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.

Byrd JB, Brook RD.

J Hum Hypertens. 2014 Jan;28(1):3-9. doi: 10.1038/jhh.2013.42. Epub 2013 May 23. Review.

PMID:
23698003
42.

Data quality of an electronic health record tool to support VA cardiac catheterization laboratory quality improvement: the VA Clinical Assessment, Reporting, and Tracking System for Cath Labs (CART) program.

Byrd JB, Vigen R, Plomondon ME, Rumsfeld JS, Box TL, Fihn SD, Maddox TM.

Am Heart J. 2013 Mar;165(3):434-40. doi: 10.1016/j.ahj.2012.12.009. Epub 2013 Jan 19.

PMID:
23453115
43.

Detection and recognition of hypertension in anxious and depressed patients.

Byrd JB, Powers JD, Magid DJ, Tavel HM, Schmittdiel JA, O'Connor PJ, Beck AL, Butler MG, Ho PJ.

J Hypertens. 2012 Dec;30(12):2293-8. doi: 10.1097/HJH.0b013e328359b6e6.

PMID:
23032145
44.

Upper and middle trunk brachial plexopathy after robotic prostatectomy.

Devarajan J, Byrd JB, Gong MC, Wood HM, O'Hara J, Weingarten TN, Warner MA, Warner ME, Sprung J.

Anesth Analg. 2012 Oct;115(4):867-70. Epub 2012 Jul 13.

PMID:
22798532
45.

Pericardial effusion in renal disease: to tap or not to tap.

Krantz MJ, Byrd JB.

Cardiology. 2011;120(4):204-8. doi: 10.1159/000335482. Epub 2012 Jan 27.

PMID:
22286154
46.

Combination therapy as initial treatment for newly diagnosed hypertension.

Byrd JB, Zeng C, Tavel HM, Magid DJ, O'Connor PJ, Margolis KL, Selby JV, Ho PM.

Am Heart J. 2011 Aug;162(2):340-6. doi: 10.1016/j.ahj.2011.05.010. Epub 2011 Jul 18.

47.

The possibility of unmeasured confounding variables in observational studies: a forgotten fact?

Byrd JB, Ho PM.

Heart. 2011 Nov;97(22):1815-6. doi: 10.1136/heartjnl-2011-300630. Epub 2011 Jul 27. No abstract available.

PMID:
21795300
48.

Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema.

Woodard-Grice AV, Lucisano AC, Byrd JB, Stone ER, Simmons WH, Brown NJ.

Pharmacogenet Genomics. 2010 Sep;20(9):532-6. doi: 10.1097/FPC.0b013e32833d3acb.

49.

Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use.

Byrd JB, Woodard-Grice A, Stone E, Lucisano A, Schaefer H, Yu C, Eyler AE, Salloum NE, Brown NJ.

Allergy. 2010 Nov;65(11):1381-7. doi: 10.1111/j.1398-9995.2010.02398.x.

50.

Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.

Van Guilder GP, Pretorius M, Luther JM, Byrd JB, Hill K, Gainer JV, Brown NJ.

Hypertension. 2008 Feb;51(2):454-9. doi: 10.1161/HYPERTENSIONAHA.107.102574. Epub 2008 Jan 7.

Supplemental Content

Support Center